Pacific Biosciences of California PACB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$128.58M+80.5% | -$546.38M-75.0% | -$506.01M-28.3% | -$528.73M-32.1% | -$660.12M-122% | ||
| $10.06M-35.8% | $12.99M-5.7% | $13.09M-5.9% | $14.83M+17.5% | $15.67M+31.1% | ||
| $36.93M-39.2% | $41.67M-41.3% | $48.11M-32.8% | $55.39M-24.1% | $60.71M-17.6% | ||
| -$111.84M+35.9% | -$111.21M+46.0% | -$122.79M+47.3% | -$149.55M+40.8% | -$174.43M+27.4% | ||
| $4.45M— | $2.8M— | $3.56M— | —— | —— | ||
| $106.07M-47.8% | $115.45M-6.9% | $147.66M— | $151.82M— | $203.37M— | ||
| —— | —— | —— | —— | -$47.58M— | ||
| -$2.87M— | $7.67M— | -$21.91M— | -$45.16M— | —— | ||
| -$116.21M+34.8% | -$113.92M+46.3% | -$126.26M+47.3% | -$152.32M+41.6% | -$178.13M+28.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pacific Biosciences of California generate?
- Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
- What is Pacific Biosciences of California's free cash flow?
- After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
- Where does Pacific Biosciences of California's cash flow data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
